Unity Accounts Payable vs Property Plant And Equipment Net Analysis

UBX Stock  USD 1.14  0.02  1.72%   
Unity Biotechnology financial indicator trend analysis is much more than just breaking down Unity Biotechnology prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Unity Biotechnology is a good investment. Please check the relationship between Unity Biotechnology Accounts Payable and its Property Plant And Equipment Net accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unity Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.

Accounts Payable vs Property Plant And Equipment Net

Accounts Payable vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Unity Biotechnology Accounts Payable account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have weak relationship.
The correlation between Unity Biotechnology's Accounts Payable and Property Plant And Equipment Net is 0.32. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Unity Biotechnology, assuming nothing else is changed. The correlation between historical values of Unity Biotechnology's Accounts Payable and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Unity Biotechnology are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Accounts Payable i.e., Unity Biotechnology's Accounts Payable and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

0.32
Relationship DirectionPositive 
Relationship StrengthVery Weak

Accounts Payable

An accounting item on the balance sheet that represents Unity Biotechnology obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Unity Biotechnology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from Unity Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Unity Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unity Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.At this time, Unity Biotechnology's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 83.88 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 4.9 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses61.4M57.8M44.7M67.0M
Cost Of Revenue2.9M2.2M19.7M14.1M

Unity Biotechnology fundamental ratios Correlations

0.890.720.780.290.70.40.42-0.170.83-0.470.460.630.630.870.79-0.06-0.50.29-0.060.28-0.460.130.340.860.65
0.890.810.910.430.810.440.52-0.350.98-0.640.460.730.740.760.830.18-0.760.48-0.390.47-0.730.340.60.740.8
0.720.810.85-0.020.840.790.84-0.760.73-0.820.730.220.450.430.520.56-0.810.81-0.490.81-0.770.740.760.40.74
0.780.910.850.170.780.560.75-0.520.9-0.880.570.530.540.580.780.34-0.930.59-0.550.64-0.910.50.810.550.76
0.290.43-0.020.170.07-0.36-0.410.410.530.22-0.320.610.760.490.46-0.41-0.02-0.32-0.09-0.27-0.02-0.31-0.170.50.09
0.70.810.840.780.070.630.67-0.70.77-0.680.590.50.480.480.570.59-0.710.81-0.330.7-0.670.620.730.460.67
0.40.440.790.56-0.360.630.9-0.870.32-0.720.97-0.060.26-0.080.350.64-0.590.84-0.120.91-0.550.830.73-0.10.7
0.420.520.840.75-0.410.670.9-0.880.45-0.940.870.00.150.020.410.71-0.830.86-0.420.92-0.810.820.9-0.010.67
-0.17-0.35-0.76-0.520.41-0.7-0.87-0.88-0.290.77-0.770.13-0.070.2-0.13-0.920.68-0.980.43-0.960.66-0.93-0.830.23-0.53
0.830.980.730.90.530.770.320.45-0.29-0.620.350.770.770.750.840.17-0.760.42-0.440.41-0.740.260.580.730.72
-0.47-0.64-0.82-0.880.22-0.68-0.72-0.940.77-0.62-0.71-0.17-0.24-0.16-0.53-0.640.96-0.780.61-0.840.95-0.71-0.94-0.13-0.67
0.460.460.730.57-0.320.590.970.87-0.770.35-0.710.050.35-0.030.490.55-0.570.750.010.84-0.540.690.69-0.050.73
0.630.730.220.530.610.5-0.060.00.130.77-0.170.050.690.680.77-0.16-0.340.03-0.01-0.04-0.35-0.180.210.680.56
0.630.740.450.540.760.480.260.15-0.070.77-0.240.350.690.510.83-0.06-0.380.160.00.24-0.350.070.260.510.57
0.870.760.430.580.490.48-0.080.020.20.75-0.16-0.030.680.510.61-0.32-0.28-0.05-0.11-0.13-0.25-0.220.031.00.35
0.790.830.520.780.460.570.350.41-0.130.84-0.530.490.770.830.61-0.02-0.590.22-0.030.31-0.570.060.480.60.66
-0.060.180.560.34-0.410.590.640.71-0.920.17-0.640.55-0.16-0.06-0.32-0.02-0.580.91-0.450.81-0.580.790.73-0.350.33
-0.5-0.76-0.81-0.93-0.02-0.71-0.59-0.830.68-0.760.96-0.57-0.34-0.38-0.28-0.59-0.58-0.720.73-0.771.0-0.66-0.93-0.25-0.71
0.290.480.810.59-0.320.810.840.86-0.980.42-0.780.750.030.16-0.050.220.91-0.72-0.440.93-0.70.90.84-0.070.62
-0.06-0.39-0.49-0.55-0.09-0.33-0.12-0.420.43-0.440.610.01-0.010.0-0.11-0.03-0.450.73-0.44-0.450.74-0.52-0.61-0.08-0.23
0.280.470.810.64-0.270.70.910.92-0.960.41-0.840.84-0.040.24-0.130.310.81-0.770.93-0.45-0.740.950.9-0.160.63
-0.46-0.73-0.77-0.91-0.02-0.67-0.55-0.810.66-0.740.95-0.54-0.35-0.35-0.25-0.57-0.581.0-0.70.74-0.74-0.63-0.92-0.22-0.69
0.130.340.740.5-0.310.620.830.82-0.930.26-0.710.69-0.180.07-0.220.060.79-0.660.9-0.520.95-0.630.81-0.250.54
0.340.60.760.81-0.170.730.730.9-0.830.58-0.940.690.210.260.030.480.73-0.930.84-0.610.9-0.920.810.00.66
0.860.740.40.550.50.46-0.1-0.010.230.73-0.13-0.050.680.511.00.6-0.35-0.25-0.07-0.08-0.16-0.22-0.250.00.33
0.650.80.740.760.090.670.70.67-0.530.72-0.670.730.560.570.350.660.33-0.710.62-0.230.63-0.690.540.660.33
Click cells to compare fundamentals

Unity Biotechnology Account Relationship Matchups

Unity Biotechnology fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets151.2M156.3M124.7M124.4M65.7M100.2M
Other Current Liab12.0M7.4M7.0M5.3M3.0M5.5M
Total Current Liabilities17.2M14.5M16.6M19.6M7.8M14.3M
Total Stockholder Equity120.7M82.9M59.6M66.8M28.4M27.0M
Other Liab3.3M4.1M13.3M23K26.5K25.1K
Net Tangible Assets120.7M82.9M59.6M66.8M76.9M57.5M
Property Plant And Equipment Net16.6M36.1M31.2M26.9M18.1M19.9M
Net Debt(37.4M)41.2M18.7M34.6M7.2M7.5M
Retained Earnings(245.5M)(339.3M)(400.0M)(460.0M)(484.4M)(460.1M)
Accounts Payable5.2M2.6M2.0M1.8M1.4M2.1M
Cash37.5M17.8M32.9M12.7M19.8M23.3M
Non Current Assets Total21.7M55.5M34.2M27.8M19.1M25.2M
Non Currrent Assets Other2.1M1.4M987K52K1.0M981.1K
Other Assets2.1M1.4M987K948K853.2K992.6K
Cash And Short Term Investments127.5M97.7M88.1M94.8M43.2M79.8M
Common Stock Shares Outstanding4.4M5.1M5.6M9.5M14.8M15.5M
Short Term Investments90.0M79.9M55.2M82.1M23.4M22.2M
Liabilities And Stockholders Equity151.2M156.3M124.7M124.4M65.7M100.2M
Non Current Liabilities Total13.3M59.0M48.5M37.9M29.5M33.0M
Capital Surpluse324.7M366.7M422.4M527.0M606.1M636.4M
Other Current Assets2.0M6.3M2.4M1.5M1.8M2.1M
Other Stockholder Equity366.1M422.2M459.6M500.8M512.8M355.1M
Total Liab30.5M73.4M65.1M57.5M37.3M43.4M
Property Plant And Equipment Gross16.6M12.6M31.2M26.9M27.3M17.9M
Total Current Assets129.5M100.9M90.5M96.5M46.6M81.9M
Accumulated Other Comprehensive Income90K5K(44K)(251K)(24K)(25.2K)
Common Stock3K4K5K6K2K3.7K
Property Plant Equipment16.6M36.1M31.2M7.8M9.0M16.9M
Net Invested Capital120.7M107.4M81.0M87.2M28.4M27.0M
Net Working Capital112.3M86.4M73.9M76.9M38.8M71.5M
Short Long Term Debt Total45K59.0M51.6M47.4M27.0M33.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Unity Stock Analysis

When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.